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ABSTRACT 
Genetic Variation and the Teratogenic Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin During 
Cardiogenesis 
 
 
Diana Sofia Bueso-Mendoza 
Department of Veterinary Medicine and Biomedical Sciences 
Texas A&M University 
 
 
Research Advisor: Dr. David W. Threadgill 
Department of Molecular and Cellular Medicine 
Texas A&M University 
 
 
 Dioxins have historically been known to cause adverse health effects in humans1. 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD, dioxin), is a byproduct of forest fires, waste incineration, 
automobile exhaust, cigarette smoke, and other combustion processes2. While TCDD is a known 
teratogen, it has also been linked to lowered sperm counts in male rats3, cleft palate formation 
during embryogenesis4, and kidney blockage2. To better understand the teratogenic effects of 
dioxin, we studied its effect on cardiogenesis. By collecting embryonic hearts from various 
mouse strains, we investigated potential links between prenatal TCDD exposure and the 
expression of major genes involved in cardiogenesis. Embryonic hearts were dissected from 
mice that were prenatally exposed to 0, 1, or 100 ng/kg per day of dioxin. Preliminary data 
shows significant strain-dependent differences in expression of master regulator genes, such 
as GATA4. We also see delayed expression of other downstream genes involved in heart 
development that have been known to cause congenital heart defects. 
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NOMENCLATURE 
 
TCDD  2,3,7,8-Tetrachlorodibenzo-p-dioxin 
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CHAPTER I 
INTRODUCTION 
 
Dioxins have been known to cause malformations during embryogenesis. Particularly, 
2,3,7,8-tetrachlorodibenzo-p-dioxin, is a potent dioxin commonly found in the environment from 
combustion processes in industrial facilities. In many locations, these combustion plants are 
common which leaves humans, especially pregnant mothers, vulnerable to dioxin’s potent 
effects.  
TCDD’s potent response is mediated by interactions with aryl hydrocarbon receptor 
(AHR). Normally AHR stays in the cytoplasm in a complex with several proteins, including 
heat-shock protein 90. However, when TCDD binds to the AHR, it disassociates from the 
complex and travels to the nucleus. There the AHR-TCDD complex binds to AHR nuclear 
translocator (ARNT). The active complex then binds to dioxin response elements within DNA.6 
 
Cardiogenesis 
 Since pregnant mothers are highly susceptible to toxicants in the environment, and 
specifically teratogens, this study focused on pregnant mothers exposed to TCDD. The heart is 
one of the first organs to develop and can be used to determine toxicity early. TCDD has been 
known to interact with the mechanisms necessary for development. In an organ such as the heart, 
this can cause major implications for future development and can cause complications later on in 
life. In a previous experiment, hearts from chicks were observed after treating with TCDD. Ten 
out of the thirteen observed TCDD exposed hearts had enlarged right and left ventricles, 
thickened ventricular septum, and thinner left ventricular walls with increased trabeculation. 
5 
Furthermore, AHR and ARNT expression was found in the myocytes of developing 
atrioventricular canal, outflow tract, and atrial and ventricular septa. This indicated that the 
developing myocardium and cardiac septa are targets for TCDD-induced toxicity.7  
Many genes involved in cardiogenesis were quantified in this study. Those genes include: 
Nkx 2-5 ORF, Hand1, Hand2, Gata4, Tbx3, Tbx5, Tbx20, GAPDH, β-actin, Pitx2, and Mef2c. 
These genes were chosen based on their critical roles in developing hearts, a summary of their 
affects are shown in Figure 1. Nkx2-5 encodes a homeobox-containing transcription factor. 
Mutations in the gene can lead to atrial septal with atrial ventricular conduction defect. Hand1 
and Hand2 are part of the helix-loop-helix transcription factors. Both Hand1 and Hand2 create 
proteins that work complementarily to create the right ventricle and aortic arch arteries.8  
  
Figure 1. Segmented genes based on defect location.9 
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Gata4 is thought to regulate genes involved in myocardial differentiation and function. 
Mutations in this gene have been implicated in cardiac septal defects. Along with Tbx5, it binds 
to cardiac super-enhancers and promotes cardiomyocyte gene expression and downregulates 
endocardial gene expression.10 Tbx3, Tbx5, and Tbx20 are all part of the T-box family, which are 
classified based on their common DNA binding domain. T-box genes maintain transcription 
factors involved in the regulation of embryogenesis. However, Tbx5 and Tbx20 are more 
implicated in heart defects. Tbx20 is critical for heart formation where the gene can lead to 
defects in septation, valvulogenesis, and cardiomyopathy.8 GAPDH and β-actin are found in all 
cells and respectively help create energy and motility for the cell. Pitx2 creates a protein 
involved in the development of abdominal organs. Mef2c is a transcription activator in humans 
and binds to the MEF2 element in regulatory regions of muscles, which can control cardiac 
morphogenesis and myogenesis. The genes described above are critical in some aspects of 
cardiogenesis. Through this experiment, information will be garnered that will help determine 
TCDD’s affect on genes related to cardiogenesis. This information may then be related back to 
human exposure to TCDD and how pregnant woman may be affected. Gata4 and Nkx2-5 are of 
particular importance in this study due to their regulation of downstream genes. Figure 2 
demonstrates a few of these regulating pathways.  
Along with genes critical for heart formation, two other genes, Cyp1a1 and Cyp1b1, were 
also analyzed to determine their role in TCDD exposure. Cyp1a1 and Cyp1b1 are 
monooxygenases that help catalyze many reactions related to drug metabolism.8 If these two 
genes are upregulated in developing hearts treated with TCDD, then they may have a role in 
TCDD metabolism, which may be a topic of further study. 
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Figure 2: Gata4 and Nkx2-5 regulating cascade pathways.11 
 
Mouse Models 
 Mouse models are used due to their genetic diversity, which can reflect that of humans. 
The embryos collected during this study were from mouse strains that span a variety of families, 
and included A/J, NOD/ShiltJ, NZO/HiltJ, and BALB/cJ, CC019, CC041, DBA/1J, 
129S1/SvlmJ, CBA/J, FVB/NJ, and BXD40. These strains were selected based on their genetic 
background and their ability to mimic the genetic variance found within the general human 
population. For instance, A/J have a genetic mutation that causes their hind limbs to under 
develop. As a result, these mice move slowly and represent individuals who exercise very little. 
8 
NZO/HiltJs are severely obese and can be used to study both obesity and Type 2 Diabetes. While 
other mice, such as FVB/NJ and BALB/cJ demonstrate the average human individual.  
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CHAPTER II 
METHODS 
 
Embryonic heart RNA was collected from an experiment at Texas A&M University that 
used TCDD treated mice to determine the relationship between dioxin exposure and developing 
embryos. The mice were chosen based on strain fecundity and variations in genetic traits. In the 
study, pregnant mothers were dosed with 0, 1, or 100 ng/kg/day of dioxin in peanut butter for the 
first ten days of pregnancy. Initially the study also included 10 ng/kg and 50 ng/kg dosed mice, 
but the results were not different from those obtained from the 1 ng/kg dosed mice. 
On the first and tenth day of pregnancy, the mice were weighed and given an MRI for 
body composition. Based on these results, the mice were divided into groups based on weight 
and were dosed accordingly. Each day, except day ten, the mice were given peanut butter 
containing a specified dose of TCDD in the morning. On the tenth day of pregnancy, the mice 
were dosed through oragastric gavage and dissected to confirm pregnancy and collect various 
organs, such as the uterus.  
Using a Leica Light Microscope, the uterus was separated into placentas and embryos. 
The placentas were collected in a separate tube while the embryonic hearts were removed from 
the embryos and placed in tubes containing RNA later. Any abnormalities were kept in a 
separate tube and cited within the research notes. 
The embryonic hearts were then treated to isolate the RNA from the hearts. The collected 
RNA was then run through a Cytation Imaging Reader to determine the amounts of RNA 
collected. These values were not sufficient to follow the normalization protocol in order to make 
10 
cDNA, however the light cycler at the end of the procedure does not require exact concentration 
amounts. 
 
cDNA Plate Preparation 
Since it was discovered in the previous experiment that the quantities of RNA were not 
enough to follow the normalized method for cDNA preparation, this step was skipped in order to 
use all RNA available. As a result, 10ųL of RNA was used in each well of 96-well  skirted 
plates. From this method, a reference plate was made along with fourteen plates containing 
samples. These plates were inserted into the Eppendorf epMotion 5075 robot. Using a Qiagen 
QuantiTect Reverse Transcription Kit, the robot combined quantities of gDNA wipeout buffer, 
quantiscript reverse transcriptase, quantiscript RT buffer, and RT primer mix. The gDNA 
wipeout buffer removes any contaminate genomic DNA, while the other components efficiently 
reverse transcribe the RNA into cDNA. Thirteen plates were made using this method. 
 
qPCR Plate Preparation 
qPCR was utilized to detect specific DNA sequences and quantify these sequences. For 
this project, cDNA plates prepared in the previous steps were used to prepare a qPCR plate 
inside of an Eppendorf epMotion 5075 robot. The cDNA plates provided the samples and then 
reagents were measured for creating the new plate. The reagents used were SYBR Green, 
specific DNA primers, and PCR grade water. SYBR Green works as a DNA or RNA stain. 
Primers serve as a starting point for DNA synthesis. By selecting what primers to use, certain 
DNA strands could be replicated. PCR grade water must be used to prevent contamination as the 
robot formulates the correct concentrations for the Master Mix. These reagents were added to 
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three individual 2 mL Eppendorf tubes. A fourth 2 mL tube was left empty to perform as the 
Master Mix tube, a concentration-specific mixture of the reagents combined by the robot. Once 
all reagents were prepared and placed into the robot, along with the cDNA plate, pipettes, pipette 
tips, and a qPCR plate, the robot could initiate its application. To create the qPCR plate, the 
robot used various pipettes as it transferred samples and reagents from the cDNA plate to an 
empty qPCR plate.  
 
LightCycler 
Following qPCR, the qPCR plate was sealed then vortexed and centrifuged to ensure a 
clear reading when placed into the LightCycler. The LightCycler detects expression of genes 
from the fluorescence of the SYBR Green. An early logarithmic curve means a higher quantity 
of gene expression. The results are then compared to a normalized figure of expression per gene. 
Any qPCR plates that had abnormal readings, were rerun by making another qPCR plate with the 
same gene. This was to confirm the abnormal readings or correct readings that were inaccurate.  
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CHAPTER III 
RESULTS 
 
Through the SYBR Green, it was discovered that certain plates had high gene expression, 
while others were nonexistent. Lowered gene expression is concerning in plates, due to its 
implication to cardiogenesis. Those genes that lack expression allude to cardiogenesis slowing 
and not forming the chambers of the heart in correct sequence. Severe complications could even 
lead to a lack of conductance in a fully formed heart.  
Currently, only 3-7 mice are used for the results listed below. Performing qPCR on the 
remaining samples will increase the number of mice per strain and solidify the preliminary data 
from the study. Data from more mice strains will also be obtained to observe how TCDD affects 
them as a result of their genetic background. Gene expression for the remaining genes in the 
study will be quantified as well. 
Additionally, the 1ng/kg dioxin dosed mice were removed from the results of the study 
because there was no marked differences in the values of gene expression.  
 
Lowered Gene Expression 
 Preliminary results indicate down regulation of the Nkx2-5 gene. When the results from 
the mice strains are pooled together, a marked decrease in Nkx2-5 gene expression can be seen 
from the control mice to the mice dosed with dioxin. These results are shown in Figure 3. When 
looking at specific strains of mice, the decrease in Nkx2-5 is accentuated. This is especially 
significant in the A/J strain of mice. There is also a trend in down regulation for BALB/cJ, 
FVB/NJ, and C57BL/6J. 
13 
 
Figure 3: TCDD effect on combined mice strains genetic expression of Nkx2-5.  
 
There was little to no change in BXD40 strain of mice. Figure 4 summarizes the findings. 
This significant decrease in Nkx2-5 is concerning. Since Nkx2-5 is a regulator of many 
pathways that affect the heart’s development, this means that these pathways will also be less 
activated. This could impair valve and vessel formation along with septal formation of both the 
ventricles and atriums. Many of these fetuses will not survive to birth. Those that do will be born 
with congenital heart malformations, such as a hole in the heart. In humans, these children would 
need to be operated on or they will face many problems performing life-sustaining functions.  
14 
Overall the data suggests that dioxin impairs cardiogenesis through downregulating the 
expression of the gene Nkx2-5, which is of paramount importance. 
Figure 4: Interstrain variability of Nkx2-5 expression from TCDD exposure. 
 
Higher Gene Expression 
 An unexpected result was the increase in Gata4 expression in some of the mice strains 
sampled. When pooled together, the results of upregulation are almost negligible as shown in 
Figure 5. There is only a slight increase in gene expression from the control mice to those dosed 
with 100ng/kg. However, when the data is separated out into the various strains, as shown in 
Figure 6, it can be observed that certain strains show upregulation in the Gata4 gene.  
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Figure 5: TCDD effect on combined mice strains genetic expression of Gata4. 
 
The strains A/J, BXD40, FVB/NJ, and NOD/ShiLtJ followed this trend in upregulation. 
However, the strains BALB/cJ and C57BL/6J followed the expected outcome of a 
downregulation in Gata4 to correspond with the trend for Nkx2-5.  
While it is uncertain why this upregulation occurs in certain mouse strains, there are a 
few ideas. One of these ideas is that TCDD may slow down cardiogenesis and embryonic 
development in general. The expression of the other genes in this study may be able to help glean 
more information on cardiogenesis depression.  
16 
 
Figure 6: Interstrain variability of Gata4 expression from TCDD exposure. 
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CHAPTER IV 
CONCLUSION 
 
The findings suggest that TCDD has slowed the progression of cardiogenesis for some 
strains of mice. This is contingent on the mice strain’s ability to with is expected to cause septal 
and conductance defects in the embryos. This will cause the embryo to no longer be viable or if 
it is viable it will be left with many congenital heart issues that will have to be treated later on. 
Additionally, the slowed development, as shown by the Gata4 upregulation, will cause the 
embryo to develop more slowly exposing it to more toxicants during development. Many further 
processes in development may also progress slowly or fail to form. As a result, the baby that is 
born may be born full term, but will have the characteristics of a premature baby.  
Since humans are exposed to dioxin in small amounts over time, pregnant mothers in 
industrial towns may be at an increased risk. The results from this study suggest that human 
fetuses may be affected by TCDD by the reduction of Nkx2-5 gene and a slower progression of 
development. This may then lead to various developmental problems once the baby is born.  
Future experimentation could replicate the study using 20 pregnant mice per strain per 
dioxin category. Due to the time restraint on the original dioxin study, there was a limit on the 
number of mice that were dosed with dioxin. The experiment was limited by how many mice 
were available and how quickly mice would mate. Additionally, future experimentation can 
determine gene expression in embryonic formation at different stages of development. Once the 
heart forms, the pregnant mother can be dissected to excise the developing embryo during 
various time periods of expected heart development point. This study can test how the heart is 
18 
affected at different stages of its formation and determine whether heart formation is indeed 
slowed down by TCDD. 
With additional studies, a greater understanding of the affects of TCDD on humans can 
be determined. Mouse models will help the community become aware of the environmental 
affects of chemical pollution. The mechanisms behind these pollutants can then be discovered 
and treatments can be created.  
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